Literature DB >> 28344006

Drug-resistant tuberculosis in 2017: at a crossroads.

David W Dowdy1, Grant Theron2, Jeffrey A Tornheim3, Emily A Kendall3.   

Abstract

Entities:  

Year:  2017        PMID： 28344006      PMCID： PMC6003863          DOI： 10.1016/S2213-2600(17)30081-4

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  9 in total

Review 1.  The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Gary Maartens; Kelly E Dooley; Ruth McNerney; Megan Murray; Jennifer Furin; Edward A Nardell; Leslie London; Erica Lessem; Grant Theron; Paul van Helden; Stefan Niemann; Matthias Merker; David Dowdy; Annelies Van Rie; Gilman K H Siu; Jotam G Pasipanodya; Camilla Rodrigues; Taane G Clark; Frik A Sirgel; Aliasgar Esmail; Hsien-Ho Lin; Sachin R Atre; H Simon Schaaf; Kwok Chiu Chang; Christoph Lange; Payam Nahid; Zarir F Udwadia; C Robert Horsburgh; Gavin J Churchyard; Dick Menzies; Anneke C Hesseling; Eric Nuermberger; Helen McIlleron; Kevin P Fennelly; Eric Goemaere; Ernesto Jaramillo; Marcus Low; Carolina Morán Jara; Nesri Padayatchi; Robin M Warren
Journal:  Lancet Respir Med       Date:  2017-03-15       Impact factor: 30.700

2.  Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.

Authors:  N Sarita Shah; Sara C Auld; James C M Brust; Barun Mathema; Nazir Ismail; Pravi Moodley; Koleka Mlisana; Salim Allana; Angela Campbell; Thuli Mthiyane; Natashia Morris; Primrose Mpangase; Hermina van der Meulen; Shaheed V Omar; Tyler S Brown; Apurva Narechania; Elena Shaskina; Thandi Kapwata; Barry Kreiswirth; Neel R Gandhi
Journal:  N Engl J Med       Date:  2017-01-19       Impact factor: 91.245

Review 3.  GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs.

Authors:  Grant Theron; Jonny Peter; Marty Richardson; Rob Warren; Keertan Dheda; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2016-09-08

4.  Target regimen profiles for treatment of tuberculosis: a WHO document.

Authors:  Christian Lienhardt; Payam Nahid; Michael L Rich; Cathy Bansbach; Emily A Kendall; Gavin Churchyard; Lice González-Angulo; Lia D'Ambrosio; Giovanni Battista Migliori; Mario Raviglione
Journal:  Eur Respir J       Date:  2017-01-25       Impact factor: 16.671

5.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

6.  High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.

Authors:  A Piubello; S Hassane Harouna; M B Souleymane; I Boukary; S Morou; M Daouda; Y Hanki; A Van Deun
Journal:  Int J Tuberc Lung Dis       Date:  2014-10       Impact factor: 2.373

Review 7.  Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

Authors:  Heidi Albert; Ruvandhi R Nathavitharana; Chris Isaacs; Madhukar Pai; Claudia M Denkinger; Catharina C Boehme
Journal:  Eur Respir J       Date:  2016-07-13       Impact factor: 16.671

8.  Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.

Authors:  Emily A Kendall; Anthony T Fojo; David W Dowdy
Journal:  Lancet Respir Med       Date:  2016-12-16       Impact factor: 30.700

9.  Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.

Authors:  Emily A Kendall; Mariam O Fofana; David W Dowdy
Journal:  Lancet Respir Med       Date:  2015-11-18       Impact factor: 30.700
  9 in total
  2 in total

1.  Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting.

Authors:  Avika Dixit; Luca Freschi; Roger Vargas; Roger Calderon; James Sacchettini; Francis Drobniewski; Jerome T Galea; Carmen Contreras; Rosa Yataco; Zibiao Zhang; Leonid Lecca; Sergios-Orestis Kolokotronis; Barun Mathema; Maha R Farhat
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

2.  Tuberculosis care cascade in Zambia - identifying the gaps in order to improve outcomes: a population-based analysis.

Authors:  Patrick Lungu; Andrew D Kerkhoff; Clara C Kasapo; Judith Mzyece; Sulani Nyimbili; Rhehab Chimzizi; Andrew Silumesii; Mary Kagujje; Ramnath Subbaraman; Monde Muyoyeta; Kennedy Malama
Journal:  BMJ Open       Date:  2021-08-10       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.